CE Credit Information

Upon completion of this activity, learners should be better able to:

1. Evaluate patients with complex ocular surface disease by integrating history, eyelid and ocular-surface findings, corneal sensitivity, tear-flow assessment, and relevant risk factors.
2. Differentiate the indications, contraindications, evidence, benefits, limitations, and potential complications of contemporary OSD therapies, including treatments for Demodex blepharitis, meibomian gland dysfunction, conjunctivochalasis, lacrimal dysfunction, and corneal-surface disease.
3. Develop evidence-based, patient-specific management plans incorporating pharmaceutical, thermal, mechanical, light-based, regenerative, occlusive, and surgical or procedural options.
4. Demonstrate, in a simulated or supervised educational setting, the essential safety and technical steps for selected eyelid, meibomian gland, irrigation, occlusion, light-based, and amniotic membrane procedures within the learner’s professional scope of practice.
5. Recognize and manage procedural risks by applying appropriate patient selection, infection-prevention measures, informed-consent principles, complication recognition, documentation, follow-up, and referral criteria.
6. Collaborate with members of the interprofessional eye-care team to coordinate patient education, procedural preparation, monitoring, and longitudinal care.